Tokyo-listed Murakami Takes New Role at

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on February 24, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Tokyo-listed Murakami Takes New Role at Maruto Sangyo

Source disclosure: February 24, 2026 Maruto Sangyo [7894.F] TOKYO, Feb 24 (Pulse News Wire) – Maruto Sangyo (7894.T) announced today that its board of directors appointed Murakami Takahiro as a new executive officer effective March 1, 2026. Murakami was previously serving as the head of the West Japan Division within the Pharmaceutical Business Department. In his new role, he will take on responsibilities as the director of the Corporate Planning Office. This appointment follows rec